JPWO2020112583A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2020112583A5 JPWO2020112583A5 JP2021529452A JP2021529452A JPWO2020112583A5 JP WO2020112583 A5 JPWO2020112583 A5 JP WO2020112583A5 JP 2021529452 A JP2021529452 A JP 2021529452A JP 2021529452 A JP2021529452 A JP 2021529452A JP WO2020112583 A5 JPWO2020112583 A5 JP WO2020112583A5
- Authority
- JP
- Japan
- Prior art keywords
- difluoro
- methoxyphenyl
- amino
- pyrrolidin
- phenyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 125000003545 alkoxy group Chemical group 0.000 claims 15
- 125000001475 halogen functional group Chemical group 0.000 claims 13
- 125000000217 alkyl group Chemical group 0.000 claims 12
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 11
- 125000001188 haloalkyl group Chemical group 0.000 claims 9
- 150000003839 salts Chemical class 0.000 claims 9
- 150000001875 compounds Chemical class 0.000 claims 8
- 125000004076 pyridyl group Chemical group 0.000 claims 8
- 125000001424 substituent group Chemical group 0.000 claims 8
- 125000004093 cyano group Chemical group *C#N 0.000 claims 7
- 125000000753 cycloalkyl group Chemical group 0.000 claims 7
- 125000004438 haloalkoxy group Chemical group 0.000 claims 7
- -1 isoxazolopyridinyl Chemical group 0.000 claims 4
- 125000002098 pyridazinyl group Chemical group 0.000 claims 4
- 125000004644 alkyl sulfinyl group Chemical group 0.000 claims 3
- 125000004414 alkyl thio group Chemical group 0.000 claims 3
- 125000003709 fluoroalkyl group Chemical group 0.000 claims 3
- 125000004440 haloalkylsulfinyl group Chemical group 0.000 claims 3
- 125000004995 haloalkylthio group Chemical group 0.000 claims 3
- 229910052739 hydrogen Inorganic materials 0.000 claims 3
- 239000001257 hydrogen Substances 0.000 claims 3
- 125000001715 oxadiazolyl group Chemical group 0.000 claims 3
- 125000003373 pyrazinyl group Chemical group 0.000 claims 3
- 125000003226 pyrazolyl group Chemical group 0.000 claims 3
- 125000000714 pyrimidinyl group Chemical group 0.000 claims 3
- 125000001113 thiadiazolyl group Chemical group 0.000 claims 3
- IXUHUMAWPAWIAE-XRZUKUFWSA-N (3S,4R)-3-[[5-[2-(4-chlorophenyl)cyclopropyl]-1,3,4-oxadiazol-2-yl]amino]-4-(2,6-difluoro-4-methoxyphenyl)pyrrolidin-2-one Chemical compound COC1=CC(=C(C(=C1)F)[C@@H]2CNC(=O)[C@H]2NC3=NN=C(O3)C4CC4C5=CC=C(C=C5)Cl)F IXUHUMAWPAWIAE-XRZUKUFWSA-N 0.000 claims 2
- 208000019622 heart disease Diseases 0.000 claims 2
- 239000000203 mixture Substances 0.000 claims 2
- 208000010125 myocardial infarction Diseases 0.000 claims 2
- 239000008194 pharmaceutical composition Substances 0.000 claims 2
- HNJBEVLQSNELDL-UHFFFAOYSA-N pyrrolidin-2-one Chemical compound O=C1CCCN1 HNJBEVLQSNELDL-UHFFFAOYSA-N 0.000 claims 2
- QTGWYFGAFUIAHH-XPTSAGLGSA-N (3S,4R)-3-[(6-chloro-[1,2]oxazolo[4,5-b]pyridin-3-yl)amino]-4-(2,6-difluoro-4-methoxyphenyl)pyrrolidin-2-one Chemical compound COC1=CC(=C(C(=C1)F)[C@@H]2CNC(=O)[C@H]2NC3=NOC4=C3N=CC(=C4)Cl)F QTGWYFGAFUIAHH-XPTSAGLGSA-N 0.000 claims 1
- DCBXLWBHLRKESD-ZBEGNZNMSA-N (3S,4R)-3-[[5-(4-chloro-2-fluorophenyl)-1,3,4-oxadiazol-2-yl]amino]-4-(2,6-difluoro-4-methoxyphenyl)pyrrolidin-2-one Chemical compound COC1=CC(=C(C(=C1)F)[C@@H]2CNC(=O)[C@H]2NC3=NN=C(O3)C4=C(C=C(C=C4)Cl)F)F DCBXLWBHLRKESD-ZBEGNZNMSA-N 0.000 claims 1
- BAOSYKFXUYFZDU-GUYCJALGSA-N (3S,4R)-3-[[5-(4-chlorophenyl)-1,3,4-oxadiazol-2-yl]amino]-4-(2,6-difluoro-4-methoxyphenyl)-1-methylpyrrolidin-2-one Chemical compound CN1C[C@H]([C@@H](C1=O)NC2=NN=C(O2)C3=CC=C(C=C3)Cl)C4=C(C=C(C=C4F)OC)F BAOSYKFXUYFZDU-GUYCJALGSA-N 0.000 claims 1
- ZOEUPAGSWHQKAA-LRDDRELGSA-N (3S,4R)-3-[[5-(4-chlorophenyl)-1,3,4-thiadiazol-2-yl]amino]-4-(2,6-difluoro-4-methoxyphenyl)pyrrolidin-2-one Chemical compound COC1=CC(=C(C(=C1)F)[C@@H]2CNC(=O)[C@H]2NC3=NN=C(S3)C4=CC=C(C=C4)Cl)F ZOEUPAGSWHQKAA-LRDDRELGSA-N 0.000 claims 1
- TTXIGXQILCTKMI-BONVTDFDSA-N (3S,4R)-3-[[5-(6-chloropyridin-3-yl)-1,3,4-oxadiazol-2-yl]amino]-4-(2,6-difluoro-4-methoxyphenyl)pyrrolidin-2-one Chemical compound COC1=CC(=C(C(=C1)F)[C@@H]2CNC(=O)[C@H]2NC3=NN=C(O3)C4=CN=C(C=C4)Cl)F TTXIGXQILCTKMI-BONVTDFDSA-N 0.000 claims 1
- BQWRBDVYOXNXJZ-BONVTDFDSA-N (3S,4R)-3-[[5-(6-chloropyridin-3-yl)-1,3,4-thiadiazol-2-yl]amino]-4-(2,6-difluoro-4-methoxyphenyl)pyrrolidin-2-one Chemical compound COC1=CC(=C(C(=C1)F)[C@@H]2CNC(=O)[C@H]2NC3=NN=C(S3)C4=CN=C(C=C4)Cl)F BQWRBDVYOXNXJZ-BONVTDFDSA-N 0.000 claims 1
- FUTGETDLVPKGGC-XRZUKUFWSA-N (3S,4R)-3-[[5-[2-(3-chlorophenyl)cyclopropyl]-1,3,4-oxadiazol-2-yl]amino]-4-(2,6-difluoro-4-methoxyphenyl)pyrrolidin-2-one Chemical compound COC1=CC(F)=C([C@H](CNC2=O)[C@@H]2NC2=NN=C(C(C3)C3C3=CC(Cl)=CC=C3)O2)C(F)=C1 FUTGETDLVPKGGC-XRZUKUFWSA-N 0.000 claims 1
- YGXZSRJMFBHAQI-LQEHGROVSA-N (3S,4R)-3-[[5-[2-(4-chloro-2-fluorophenyl)cyclopropyl]-1,3,4-oxadiazol-2-yl]amino]-4-(2,6-difluoro-4-methoxyphenyl)pyrrolidin-2-one Chemical compound COC1=CC(F)=C([C@H](CNC2=O)[C@@H]2NC2=NN=C(C(C3)C3C(C=CC(Cl)=C3)=C3F)O2)C(F)=C1 YGXZSRJMFBHAQI-LQEHGROVSA-N 0.000 claims 1
- WQGZQMYQPKWBRQ-AVRDEDQJSA-N (3S,4R)-3-[[5-[4-(4-chlorophenoxy)phenyl]-1,3,4-oxadiazol-2-yl]amino]-4-(2,6-difluoro-4-methoxyphenyl)pyrrolidin-2-one Chemical compound COC1=CC(F)=C([C@H](CNC2=O)[C@@H]2NC2=NN=C(C(C=C3)=CC=C3OC(C=C3)=CC=C3Cl)O2)C(F)=C1 WQGZQMYQPKWBRQ-AVRDEDQJSA-N 0.000 claims 1
- HZPUAXBCDQXVJS-XOBRGWDASA-N (3S,4R)-3-[[5-[4-(5-chloropyrazin-2-yl)oxyphenyl]-1,3,4-oxadiazol-2-yl]amino]-4-(2,6-difluoro-4-methoxyphenyl)pyrrolidin-2-one Chemical compound COC1=CC(F)=C([C@H](CNC2=O)[C@@H]2NC2=NN=C(C(C=C3)=CC=C3OC(C=N3)=NC=C3Cl)O2)C(F)=C1 HZPUAXBCDQXVJS-XOBRGWDASA-N 0.000 claims 1
- QFWADSLRJZHARC-LRDDRELGSA-N (3S,4R)-4-(2,6-difluoro-4-methoxyphenyl)-3-[(5-phenyl-1,3,4-oxadiazol-2-yl)amino]pyrrolidin-2-one Chemical compound COC1=CC(F)=C([C@H](CNC2=O)[C@@H]2NC2=NN=C(C3=CC=CC=C3)O2)C(F)=C1 QFWADSLRJZHARC-LRDDRELGSA-N 0.000 claims 1
- JOBIFNPDLOIIHK-NHYWBVRUSA-N (3S,4R)-4-(2,6-difluoro-4-methoxyphenyl)-3-[(5-pyridin-3-yl-1,3,4-oxadiazol-2-yl)amino]pyrrolidin-2-one Chemical compound COC1=CC(=C(C(=C1)F)[C@@H]2CNC(=O)[C@H]2NC3=NN=C(O3)C4=CN=CC=C4)F JOBIFNPDLOIIHK-NHYWBVRUSA-N 0.000 claims 1
- CASLQEKLSGVNHL-QFYYESIMSA-N (3S,4R)-4-(2,6-difluoro-4-methoxyphenyl)-3-[[5-(3,4-difluorophenyl)-1,3,4-oxadiazol-2-yl]amino]pyrrolidin-2-one Chemical compound COC1=CC(=C(C(=C1)F)[C@@H]2CNC(=O)[C@H]2NC3=NN=C(O3)C4=CC(=C(C=C4)F)F)F CASLQEKLSGVNHL-QFYYESIMSA-N 0.000 claims 1
- WMFMZUABTHYTBI-LRDDRELGSA-N (3S,4R)-4-(2,6-difluoro-4-methoxyphenyl)-3-[[5-(4-fluorophenyl)-1,3,4-oxadiazol-2-yl]amino]pyrrolidin-2-one Chemical compound COC1=CC(F)=C([C@H](CNC2=O)[C@@H]2NC2=NN=C(C(C=C3)=CC=C3F)O2)C(F)=C1 WMFMZUABTHYTBI-LRDDRELGSA-N 0.000 claims 1
- HELPJDYZJMEXHA-GUYCJALGSA-N (3S,4R)-4-(2,6-difluoro-4-methoxyphenyl)-3-[[5-(4-methylphenyl)-1,3,4-oxadiazol-2-yl]amino]pyrrolidin-2-one Chemical compound CC(C=C1)=CC=C1C1=NN=C(N[C@@H]([C@@H](CN2)C(C(F)=CC(OC)=C3)=C3F)C2=O)O1 HELPJDYZJMEXHA-GUYCJALGSA-N 0.000 claims 1
- WMMWDGZLOMURSR-KXBFYZLASA-N (3S,4R)-4-(2,6-difluoro-4-methoxyphenyl)-3-[[5-(4-propan-2-yloxyphenyl)-1,3,4-oxadiazol-2-yl]amino]pyrrolidin-2-one Chemical compound CC(C)OC(C=C1)=CC=C1C1=NN=C(N[C@@H]([C@@H](CN2)C(C(F)=CC(OC)=C3)=C3F)C2=O)O1 WMMWDGZLOMURSR-KXBFYZLASA-N 0.000 claims 1
- JGRQAOVEQKSKFH-KXBFYZLASA-N (3S,4R)-4-(2,6-difluoro-4-methoxyphenyl)-3-[[5-(4-propan-2-ylphenyl)-1,3,4-oxadiazol-2-yl]amino]pyrrolidin-2-one Chemical compound CC(C)C(C=C1)=CC=C1C1=NN=C(N[C@@H]([C@@H](CN2)C(C(F)=CC(OC)=C3)=C3F)C2=O)O1 JGRQAOVEQKSKFH-KXBFYZLASA-N 0.000 claims 1
- AOPILQFKSGKVMG-YWZLYKJASA-N (3S,4R)-4-(2,6-difluoro-4-methoxyphenyl)-3-[[5-(4-pyrazin-2-yloxyphenyl)-1,3,4-oxadiazol-2-yl]amino]pyrrolidin-2-one Chemical compound COC1=CC(=C(C(=C1)F)[C@@H]2CNC(=O)[C@H]2NC3=NN=C(O3)C4=CC=C(C=C4)OC5=NC=CN=C5)F AOPILQFKSGKVMG-YWZLYKJASA-N 0.000 claims 1
- IEUAMRGWIIHAQC-KJEFGLDZSA-N (3S,4R)-4-(2,6-difluoro-4-methoxyphenyl)-3-[[5-[2-(2-methoxyphenyl)cyclopropyl]-1,3,4-oxadiazol-2-yl]amino]pyrrolidin-2-one Chemical compound COC1=CC(F)=C([C@H](CNC2=O)[C@@H]2NC2=NN=C(C(C3)C3C(C=CC=C3)=C3OC)O2)C(F)=C1 IEUAMRGWIIHAQC-KJEFGLDZSA-N 0.000 claims 1
- SKQGIDWOBJNCSN-XRZUKUFWSA-N (3S,4R)-4-(2,6-difluoro-4-methoxyphenyl)-3-[[5-[2-(3,5-difluorophenyl)cyclopropyl]-1,3,4-oxadiazol-2-yl]amino]pyrrolidin-2-one Chemical compound COC1=CC(F)=C([C@H](CNC2=O)[C@@H]2NC2=NN=C(C(C3)C3C3=CC(F)=CC(F)=C3)O2)C(F)=C1 SKQGIDWOBJNCSN-XRZUKUFWSA-N 0.000 claims 1
- PHOXLGFLDWJHCA-LRDDRELGSA-N (3S,4R)-4-(2,6-difluoro-4-methoxyphenyl)-3-[[5-[4-(1,1,2,2,2-pentafluoroethylsulfanyl)phenyl]-1,3,4-oxadiazol-2-yl]amino]pyrrolidin-2-one Chemical compound COC1=CC(F)=C([C@H](CNC2=O)[C@@H]2NC2=NN=C(C(C=C3)=CC=C3SC(C(F)(F)F)(F)F)O2)C(F)=C1 PHOXLGFLDWJHCA-LRDDRELGSA-N 0.000 claims 1
- GGIOXHKVQKXKKT-YWZLYKJASA-N (3S,4R)-4-(2,6-difluoro-4-methoxyphenyl)-3-[[5-[4-(3-fluoropyridin-2-yl)oxyphenyl]-1,3,4-oxadiazol-2-yl]amino]pyrrolidin-2-one Chemical compound COC1=CC(F)=C([C@H](CNC2=O)[C@@H]2NC2=NN=C(C(C=C3)=CC=C3OC3=NC=CC=C3F)O2)C(F)=C1 GGIOXHKVQKXKKT-YWZLYKJASA-N 0.000 claims 1
- UGEXERHFIFJZDN-KKSFZXQISA-N (3S,4R)-4-(2,6-difluoro-4-methoxyphenyl)-3-[[5-[4-(5-fluoropyridin-2-yl)oxyphenyl]-1,3,4-oxadiazol-2-yl]amino]pyrrolidin-2-one Chemical compound COC1=CC(F)=C([C@H](CNC2=O)[C@@H]2NC2=NN=C(C(C=C3)=CC=C3OC(C=C3)=NC=C3F)O2)C(F)=C1 UGEXERHFIFJZDN-KKSFZXQISA-N 0.000 claims 1
- VWYWDOAVLRMAQI-BTYIYWSLSA-N (3S,4R)-4-(2,6-difluoro-4-methoxyphenyl)-3-[[5-[4-(6-fluoropyridin-2-yl)oxyphenyl]-1,3,4-oxadiazol-2-yl]amino]pyrrolidin-2-one Chemical compound COC1=CC(F)=C([C@H](CNC2=O)[C@@H]2NC2=NN=C(C(C=C3)=CC=C3OC3=NC(F)=CC=C3)O2)C(F)=C1 VWYWDOAVLRMAQI-BTYIYWSLSA-N 0.000 claims 1
- SVPBEBBDLBXAIE-AOMKIAJQSA-N (3S,4R)-4-(2,6-difluoro-4-methoxyphenyl)-3-[[5-[4-(6-methoxypyridin-2-yl)oxyphenyl]-1,3,4-oxadiazol-2-yl]amino]pyrrolidin-2-one Chemical compound COC1=CC(F)=C([C@H](CNC2=O)[C@@H]2NC2=NN=C(C(C=C3)=CC=C3OC3=NC(OC)=CC=C3)O2)C(F)=C1 SVPBEBBDLBXAIE-AOMKIAJQSA-N 0.000 claims 1
- BQLBNKFAODICPQ-BTYIYWSLSA-N (3S,4R)-4-(2,6-difluoro-4-methoxyphenyl)-3-[[5-[4-(6-methoxypyrimidin-4-yl)oxyphenyl]-1,3,4-oxadiazol-2-yl]amino]pyrrolidin-2-one Chemical compound COC1=CC(=C(C(=C1)F)[C@@H]2CNC(=O)[C@H]2NC3=NN=C(O3)C4=CC=C(C=C4)OC5=NC=NC(=C5)OC)F BQLBNKFAODICPQ-BTYIYWSLSA-N 0.000 claims 1
- IWTHSFWNUSKGFL-KKSFZXQISA-N (3S,4R)-4-(2,6-difluoro-4-methoxyphenyl)-3-[[5-[4-(6-methylpyrazin-2-yl)oxyphenyl]-1,3,4-oxadiazol-2-yl]amino]pyrrolidin-2-one Chemical compound CC1=CN=CC(OC(C=C2)=CC=C2C2=NN=C(N[C@@H]([C@@H](CN3)C(C(F)=CC(OC)=C4)=C4F)C3=O)O2)=N1 IWTHSFWNUSKGFL-KKSFZXQISA-N 0.000 claims 1
- OPZOIJLIYGVUET-LRDDRELGSA-N (3S,4R)-4-(2,6-difluoro-4-methoxyphenyl)-3-[[5-[4-(difluoromethoxy)phenyl]-1,3,4-oxadiazol-2-yl]amino]pyrrolidin-2-one Chemical compound COC1=CC(F)=C([C@H](CNC2=O)[C@@H]2NC2=NN=C(C(C=C3)=CC=C3OC(F)F)O2)C(F)=C1 OPZOIJLIYGVUET-LRDDRELGSA-N 0.000 claims 1
- IXGFRCAYDKCZPZ-DJJJIMSYSA-N (3S,4R)-4-(2,6-difluoro-4-methoxyphenyl)-3-[[5-[4-(difluoromethyl)phenyl]-1,2-oxazol-3-yl]amino]pyrrolidin-2-one Chemical compound COC1=CC(F)=C([C@H](CNC2=O)[C@@H]2NC2=NOC(C3=CC=C(C(F)F)C=C3)=C2)C(F)=C1 IXGFRCAYDKCZPZ-DJJJIMSYSA-N 0.000 claims 1
- YDBADFVDSDJNFM-LRDDRELGSA-N (3S,4R)-4-(2,6-difluoro-4-methoxyphenyl)-3-[[5-[4-(difluoromethyl)phenyl]-1,3,4-oxadiazol-2-yl]amino]pyrrolidin-2-one Chemical compound COC1=CC(=C(C(=C1)F)[C@@H]2CNC(=O)[C@H]2NC3=NN=C(O3)C4=CC=C(C=C4)C(F)F)F YDBADFVDSDJNFM-LRDDRELGSA-N 0.000 claims 1
- RJCAQJAXHDHBIQ-LRDDRELGSA-N (3S,4R)-4-(2,6-difluoro-4-methoxyphenyl)-3-[[5-[4-(difluoromethylsulfanyl)phenyl]-1,3,4-oxadiazol-2-yl]amino]pyrrolidin-2-one Chemical compound COC1=CC(F)=C([C@H](CNC2=O)[C@@H]2NC2=NN=C(C(C=C3)=CC=C3SC(F)F)O2)C(F)=C1 RJCAQJAXHDHBIQ-LRDDRELGSA-N 0.000 claims 1
- DFXGBOATHATXJQ-DJJJIMSYSA-N (3S,4R)-4-(2,6-difluoro-4-methoxyphenyl)-3-[[5-[4-(trifluoromethoxy)phenyl]-1,2-oxazol-3-yl]amino]pyrrolidin-2-one Chemical compound COC1=CC(=C(C(=C1)F)[C@@H]2CNC(=O)[C@H]2NC3=NOC(=C3)C4=CC=C(C=C4)OC(F)(F)F)F DFXGBOATHATXJQ-DJJJIMSYSA-N 0.000 claims 1
- RUZUBSJPMWAWOJ-LRDDRELGSA-N (3S,4R)-4-(2,6-difluoro-4-methoxyphenyl)-3-[[5-[4-(trifluoromethoxy)phenyl]-1,3,4-oxadiazol-2-yl]amino]pyrrolidin-2-one Chemical compound COC1=CC(=C(C(=C1)F)[C@@H]2CNC(=O)[C@H]2NC3=NN=C(O3)C4=CC=C(C=C4)OC(F)(F)F)F RUZUBSJPMWAWOJ-LRDDRELGSA-N 0.000 claims 1
- XLKARCVDHKWCKS-LRDDRELGSA-N (3S,4R)-4-(2,6-difluoro-4-methoxyphenyl)-3-[[5-[4-(trifluoromethyl)phenyl]-1,3,4-oxadiazol-2-yl]amino]pyrrolidin-2-one Chemical compound COC1=CC(=C(C(=C1)F)[C@@H]2CNC(=O)[C@H]2NC3=NN=C(O3)C4=CC=C(C=C4)C(F)(F)F)F XLKARCVDHKWCKS-LRDDRELGSA-N 0.000 claims 1
- WWJRZATUTTWCDT-LRDDRELGSA-N (3S,4R)-4-(2,6-difluoro-4-methoxyphenyl)-3-[[5-[4-(trifluoromethylsulfanyl)phenyl]-1,3,4-oxadiazol-2-yl]amino]pyrrolidin-2-one Chemical compound COC1=CC(F)=C([C@H](CNC2=O)[C@@H]2NC2=NN=C(C(C=C3)=CC=C3SC(F)(F)F)O2)C(F)=C1 WWJRZATUTTWCDT-LRDDRELGSA-N 0.000 claims 1
- WORPUWPPFCSCOH-HCWGRNRPSA-N (3S,4R)-4-(2,6-difluoro-4-methoxyphenyl)-3-[[5-[4-(trifluoromethylsulfinyl)phenyl]-1,3,4-oxadiazol-2-yl]amino]pyrrolidin-2-one Chemical compound COC1=CC(F)=C([C@H](CNC2=O)[C@@H]2NC2=NN=C(C(C=C3)=CC=C3S(C(F)(F)F)=O)O2)C(F)=C1 WORPUWPPFCSCOH-HCWGRNRPSA-N 0.000 claims 1
- QFUCDGWBZZLKIU-KKSFZXQISA-N (3S,4R)-4-(2,6-difluoro-4-methoxyphenyl)-3-[[5-[4-[6-(trifluoromethyl)pyridin-3-yl]oxyphenyl]-1,3,4-oxadiazol-2-yl]amino]pyrrolidin-2-one Chemical compound COC1=CC(F)=C([C@H](CNC2=O)[C@@H]2NC2=NN=C(C(C=C3)=CC=C3OC3=CC=C(C(F)(F)F)N=C3)O2)C(F)=C1 QFUCDGWBZZLKIU-KKSFZXQISA-N 0.000 claims 1
- FEHASKVSTUQUNL-BONVTDFDSA-N (3S,4R)-4-(2,6-difluoro-4-methoxyphenyl)-3-[[5-[5-(trifluoromethyl)pyridin-2-yl]-1,3,4-oxadiazol-2-yl]amino]pyrrolidin-2-one Chemical compound COC1=CC(=C(C(=C1)F)[C@@H]2CNC(=O)[C@H]2NC3=NN=C(O3)C4=NC=C(C=C4)C(F)(F)F)F FEHASKVSTUQUNL-BONVTDFDSA-N 0.000 claims 1
- SLBSBNFODNNEFZ-BONVTDFDSA-N (3S,4R)-4-(2,6-difluoro-4-methoxyphenyl)-3-[[5-[6-(trifluoromethyl)pyridin-3-yl]-1,3,4-oxadiazol-2-yl]amino]pyrrolidin-2-one Chemical compound COC1=CC(=C(C(=C1)F)[C@@H]2CNC(=O)[C@H]2NC3=NN=C(O3)C4=CN=C(C=C4)C(F)(F)F)F SLBSBNFODNNEFZ-BONVTDFDSA-N 0.000 claims 1
- LRMYUVNPSPTPOT-BONVTDFDSA-N (3S,4R)-4-(2,6-difluoro-4-methoxyphenyl)-3-[[5-[6-(trifluoromethyl)pyridin-3-yl]-1,3,4-thiadiazol-2-yl]amino]pyrrolidin-2-one Chemical compound COC1=CC(F)=C([C@H](CNC2=O)[C@@H]2NC2=NN=C(C3=CC=C(C(F)(F)F)N=C3)S2)C(F)=C1 LRMYUVNPSPTPOT-BONVTDFDSA-N 0.000 claims 1
- FRISEKWSFLYBKV-BONVTDFDSA-N (3S,4R)-4-(2,6-difluoro-4-methoxyphenyl)-3-[[5-[6-(trifluoromethylsulfanyl)pyridin-3-yl]-1,3,4-oxadiazol-2-yl]amino]pyrrolidin-2-one Chemical compound COC1=CC(F)=C([C@H](CNC2=O)[C@@H]2NC2=NN=C(C(C=N3)=CC=C3SC(F)(F)F)O2)C(F)=C1 FRISEKWSFLYBKV-BONVTDFDSA-N 0.000 claims 1
- JFOPMJDVYBMIIM-UWJYYQICSA-N 2-[4-[5-[[(3S,4R)-4-(2,6-difluoro-4-methoxyphenyl)-2-oxopyrrolidin-3-yl]amino]-1,3,4-oxadiazol-2-yl]phenoxy]pyridine-3-carbonitrile Chemical compound COC1=CC(F)=C([C@H](CNC2=O)[C@@H]2NC2=NN=C(C(C=C3)=CC=C3OC3=NC=CC=C3C#N)O2)C(F)=C1 JFOPMJDVYBMIIM-UWJYYQICSA-N 0.000 claims 1
- OOAHTWBNOVBNLD-JTSKRJEESA-N 2-[4-[5-[[(3S,4R)-4-(2,6-difluoro-4-methoxyphenyl)-2-oxopyrrolidin-3-yl]amino]-1,3,4-oxadiazol-2-yl]phenoxy]pyridine-4-carbonitrile Chemical compound COC1=CC(F)=C([C@H](CNC2=O)[C@@H]2NC2=NN=C(C(C=C3)=CC=C3OC3=NC=CC(C#N)=C3)O2)C(F)=C1 OOAHTWBNOVBNLD-JTSKRJEESA-N 0.000 claims 1
- AZHKDQUHLHBGRM-CVDCTZTESA-N 4-[4-[5-[[(3S,4R)-4-(2,6-difluoro-4-methoxyphenyl)-2-oxopyrrolidin-3-yl]amino]-1,3,4-oxadiazol-2-yl]phenoxy]benzonitrile Chemical compound COC1=CC(F)=C([C@H](CNC2=O)[C@@H]2NC2=NN=C(C(C=C3)=CC=C3OC(C=C3)=CC=C3C#N)O2)C(F)=C1 AZHKDQUHLHBGRM-CVDCTZTESA-N 0.000 claims 1
- GEKVFUFYEIRIKT-GUYCJALGSA-N 4-[5-[[(3S,4R)-4-(2,6-difluoro-4-methoxyphenyl)-2-oxopyrrolidin-3-yl]amino]-1,3,4-oxadiazol-2-yl]benzonitrile Chemical compound COC1=CC(=C(C(=C1)F)[C@@H]2CNC(=O)[C@H]2NC3=NN=C(O3)C4=CC=C(C=C4)C#N)F GEKVFUFYEIRIKT-GUYCJALGSA-N 0.000 claims 1
- CUTPONSEEFDLLR-JTSKRJEESA-N 6-[4-[5-[[(3S,4R)-4-(2,6-difluoro-4-methoxyphenyl)-2-oxopyrrolidin-3-yl]amino]-1,3,4-oxadiazol-2-yl]phenoxy]pyridine-2-carbonitrile Chemical compound COC1=CC(F)=C([C@H](CNC2=O)[C@@H]2NC2=NN=C(C(C=C3)=CC=C3OC3=CC=CC(C#N)=N3)O2)C(F)=C1 CUTPONSEEFDLLR-JTSKRJEESA-N 0.000 claims 1
- FYGLLWHAODEXBE-JTSKRJEESA-N 6-[4-[5-[[(3S,4R)-4-(2,6-difluoro-4-methoxyphenyl)-2-oxopyrrolidin-3-yl]amino]-1,3,4-oxadiazol-2-yl]phenoxy]pyridine-3-carbonitrile Chemical compound COC1=CC(=C(C(=C1)F)[C@@H]2CNC(=O)[C@H]2NC3=NN=C(O3)C4=CC=C(C=C4)OC5=NC=C(C=C5)C#N)F FYGLLWHAODEXBE-JTSKRJEESA-N 0.000 claims 1
- 206010002383 Angina Pectoris Diseases 0.000 claims 1
- 206010007556 Cardiac failure acute Diseases 0.000 claims 1
- 206010007558 Cardiac failure chronic Diseases 0.000 claims 1
- 206010019280 Heart failures Diseases 0.000 claims 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 1
- 206010061213 Iatrogenic injury Diseases 0.000 claims 1
- WBXKEABKCIMFQU-KSSFIOAISA-N N-[2-(4-chlorophenyl)ethyl]-5-[[(3S,4R)-4-(2,6-difluoro-4-methoxyphenyl)-2-oxopyrrolidin-3-yl]amino]-1,3,4-oxadiazole-2-carboxamide Chemical compound COC1=CC(=C(C(=C1)F)[C@@H]2CNC(=O)[C@H]2NC3=NN=C(O3)C(=O)NCCC4=CC=C(C=C4)Cl)F WBXKEABKCIMFQU-KSSFIOAISA-N 0.000 claims 1
- 208000007814 Unstable Angina Diseases 0.000 claims 1
- 230000001154 acute effect Effects 0.000 claims 1
- 125000004603 benzisoxazolyl group Chemical group O1N=C(C2=C1C=CC=C2)* 0.000 claims 1
- 125000004541 benzoxazolyl group Chemical group O1C(=NC2=C1C=CC=C2)* 0.000 claims 1
- 230000000747 cardiac effect Effects 0.000 claims 1
- 208000029078 coronary artery disease Diseases 0.000 claims 1
- 239000003085 diluting agent Substances 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 125000004428 fluoroalkoxy group Chemical group 0.000 claims 1
- 150000002431 hydrogen Chemical group 0.000 claims 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims 1
- 125000000842 isoxazolyl group Chemical group 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims 1
- 238000006467 substitution reaction Methods 0.000 claims 1
Claims (11)
R1は、不在、Ar3、0-2個のハロおよび0-1個のAr4置換基で置換されるシクロアルキル、あるいは((Ar5)アルキル)(H)NCOであり;
R2は、水素、アルキルまたはCH2CO2Hであり;
Ar1は、イソキサゾリル、オキサジアゾリル、チアジアゾリル、ベンゾイソキサゾリル、イソキサゾロピリジニル、またはベンゾオキサゾリルであって、0-2個のハロ、アルキル、アルコキシ、フルオロアルキル、またはフルオロアルコキシ置換基で置換され;
Ar2は、フェニル、ピリジニル、またはピリダジニルであって、1個のアルコキシ、ハロ、ハロアルキルまたはハロアルコキシ置換基で4位にて、および0-2個のさらなるハロ置換基で置換され;
Ar3は、フェニル、ピリジニル、ピリダジニル、ピリミジニル、またはピラジニルであって、シアノ、ハロ、アルキル、ハロアルキル、シクロアルキル、アルコキシ、(シクロアルキル)アルコキシ、ハロアルコキシ、OAr6、アルキルチオ、ハロアルキルチオ、アルキルスルフィニル、ハロアルキルスルフィニル、およびピラゾリルより選択される0-3個の置換基で置換され;
Ar4は、シアノ、ハロ、アルキル、ハロアルキル、アルコキシ、およびハロアルコキシより選択される0-3個の置換基で置換されるフェニルまたはピリジニルであり;
Ar5は、シアノ、ハロ、アルキル、ハロアルキル、アルコキシ、およびハロアルコキシより選択される0-3個の置換基で置換されるフェニルまたはピリジニルであり;および
Ar6は、フェニル、ピリジニル、ピリダジニル、ピリミジニル、またはピラジニルであって、シアノ、ハロ、アルキル、ハロアルキル、アルコキシ、およびハロアルコキシより選択される0-3個の置換基で置換される]
で示される化合物、またはその医薬的に許容される塩。 Formula I:
R 1 is absent, Ar 3 , cycloalkyl substituted with 0-2 halo and 0-1 Ar 4 substituents, or ((Ar 5 )alkyl)(H)NCO;
R2 is hydrogen, alkyl or CH2CO2H ;
Ar 1 is isoxazolyl, oxadiazolyl, thiadiazolyl, benzisoxazolyl, isoxazolopyridinyl, or benzoxazolyl with 0-2 halo, alkyl, alkoxy, fluoroalkyl, or fluoroalkoxy substitutions substituted with a group;
Ar 2 is phenyl, pyridinyl, or pyridazinyl substituted at position 4 with 1 alkoxy, halo, haloalkyl or haloalkoxy substituent and 0-2 additional halo substituents;
Ar 3 is phenyl, pyridinyl, pyridazinyl, pyrimidinyl, or pyrazinyl, cyano, halo, alkyl, haloalkyl, cycloalkyl, alkoxy, (cycloalkyl)alkoxy, haloalkoxy, OAr 6 , alkylthio, haloalkylthio, alkylsulfinyl; , haloalkylsulfinyl, and pyrazolyl substituted with 0-3 substituents;
Ar 4 is phenyl or pyridinyl substituted with 0-3 substituents selected from cyano, halo, alkyl, haloalkyl, alkoxy, and haloalkoxy;
Ar 5 is phenyl or pyridinyl substituted with 0-3 substituents selected from cyano, halo, alkyl, haloalkyl, alkoxy, and haloalkoxy; and Ar 6 is phenyl, pyridinyl, pyridazinyl, pyrimidinyl , or pyrazinyl substituted with 0-3 substituents selected from cyano, halo, alkyl, haloalkyl, alkoxy, and haloalkoxy]
A compound represented by or a pharmaceutically acceptable salt thereof.
(3S,4R)-4-(2,6-ジフルオロ-4-メトキシフェニル)-3-[(5-フェニル-1,3,4-オキサジアゾール-2-イル)アミノ]ピロリジン-2-オン
(3S,4R)-4-(2,6-ジフルオロ-4-メトキシフェニル)-3-{[5-(3,4-ジフルオロフェニル)-1,3,4-オキサジアゾール-2-イル]アミノ}ピロリジン-2-オン
(3S,4R)-4-(2,6-ジフルオロ-4-メトキシフェニル)-3-{[5-(ピリジン-3-イル)-1,3,4-オキサジアゾール-2-イル]アミノ}ピロリジン-2-オン
(3S,4R)-4-(2,6-ジフルオロ-4-メトキシフェニル)-3-({5-[4-(トリフルオロメトキシ)フェニル]-1,3,4-オキサジアゾール-2-イル}アミノ)ピロリジン-2-オン
(3S,4R)-4-(2,6-ジフルオロ-4-メトキシフェニル)-3-({5-[4-(トリフルオロメチル)フェニル]-1,3,4-オキサジアゾール-2-イル}アミノ)ピロリジン-2-オン
4-(5-{[(3S,4R)-4-(2,6-ジフルオロ-4-メトキシフェニル)-2-オキソピロリジン-3-イル]アミノ}-1,3,4-オキサジアゾール-2-イル)ベンゾニトリル
(3S,4R)-4-(2,6-ジフルオロ-4-メトキシフェニル)-3-({5-[6-(トリフルオロメチル)ピリジン-3-イル]-1,3,4-オキサジアゾール-2-イル}アミノ)ピロリジン-2-オン
(3S,4R)-4-(2,6-ジフルオロ-4-メトキシフェニル)-3-{[5-(4-メチルフェニル)-1,3,4-オキサジアゾール-2-イル]アミノ}ピロリジン-2-オン
(3S,4R)-4-(2,6-ジフルオロ-4-メトキシフェニル)-3-{[5-(4-フルオロフェニル)-1,3,4-オキサジアゾール-2-イル]アミノ}ピロリジン-2-オン
(3S,4R)-4-(2,6-ジフルオロ-4-メトキシフェニル)-3-({5-[4-(1H-ピラゾール-1-イル)フェニル]-1,3,4-オキサジアゾール-2-イル}アミノ)ピロリジン-2-オン
(3S,4R)-4-(2,6-ジフルオロ-4-メトキシフェニル)-3-({5-[5-(トリフルオロメチル)ピリジン-2-イル]-1,3,4-オキサジアゾール-2-イル}アミノ)ピロリジン-2-オン
(3S,4R)-3-{[5-(4-クロロ-2-フルオロフェニル)-1,3,4-オキサジアゾール-2-イル]アミノ}-4-(2,6-ジフルオロ-4-メトキシフェニル)ピロリジン-2-オン
(3S,4R)-3-{[5-(6-クロロピリジン-3-イル)-1,3,4-オキサジアゾール-2-イル]アミノ}-4-(2,6-ジフルオロ-4-メトキシフェニル)ピロリジン-2-オン
(3S,4R)-4-(2,6-ジフルオロ-4-メトキシフェニル)-3-({5-[4-(ジフルオロメチル)フェニル]-1,3,4-オキサジアゾール-2-イル}アミノ)ピロリジン-2-オン
(3S,4R)-4-(2,6-ジフルオロ-4-メトキシフェニル)-3-[(5-{4-[(トリフルオロメチル)スルファニル]フェニル}-1,3,4-オキサジアゾール-2-イル)アミノ]ピロリジン-2-オン
(3S,4R)-4-(2,6-ジフルオロ-4-メトキシフェニル)-3-[(5-{4-[(1,1,2,2,2-ペンタフルオロエチル)スルファニル]フェニル}-1,3,4-オキサジアゾール-2-イル)アミノ]ピロリジン-2-オン
(3S,4R)-3-{[5-(4-クロロフェニル)-1,3,4-オキサジアゾール-2-イル]アミノ}-4-(2,6-ジフルオロ-4-メトキシフェニル)-1-メチルピロリジン-2-オン
(3S,4R)-4-(2,6-ジフルオロ-4-メトキシフェニル)-3-({5-[4-(ジフルオロメチル)フェニル]-1,2-オキサゾール-3-イル}アミノ)ピロリジン-2-オン
(3S,4R)-4-(2,6-ジフルオロ-4-メトキシフェニル)-3-({5-[4-(トリフルオロメトキシ)フェニル]-1,2-オキサゾール-3-イル}アミノ)ピロリジン-2-オン
(3S,4R)-4-(2,6-ジフルオロ-4-メトキシフェニル)-3-{[5-(4-トリフルオロメタンスルフィニルフェニル)-1,3,4-オキサジアゾール-2-イル]アミノ}ピロリジン-2-オン
(3S,4R)-4-(2,6-ジフルオロ-4-メトキシフェニル)-3-[(5-{4-[(ジフルオロメチル)スルファニル]フェニル}-1,3,4-オキサジアゾール-2-イル)アミノ]ピロリジン-2-オン
(3S,4R)-4-(2,6-ジフルオロ-4-メトキシフェニル)-3-[(5-{6-[(トリフルオロメチル)スルファニル]ピリジン-3-イル}-1,3,4-オキサジアゾール-2-イル)アミノ]ピロリジン-2-オン
(3S,4R)-3-{[5-(6-クロロピリジン-3-イル)-1,3,4-チアジアゾール-2-イル]アミノ}-4-(2,6-ジフルオロ-4-メトキシフェニル)ピロリジン-2-オン
(3S,4R)-4-(2,6-ジフルオロ-4-メトキシフェニル)-3-{[5-(4-フルオロフェニル)-1,3,4-チアジアゾール-2-イル]アミノ}ピロリジン-2-オン
(3S,4R)-4-(2,6-ジフルオロ-4-メトキシフェニル)-3-({5-[6-(トリフルオロメチル)ピリジン-3-イル]-1,3,4-チアジアゾール-2-イル}アミノ)ピロリジン-2-オン
(3S,4R)-4-(2,6-ジフルオロ-4-メトキシフェニル)-3-({5-[4-(プロパン-2-イルオキシ)フェニル]-1,3,4-オキサジアゾール-2-イル}アミノ)ピロリジン-2-オン
(3S,4R)-4-(2,6-ジフルオロ-4-メトキシフェニル)-3-({5-[4-(ジフルオロメトキシ)フェニル]-1,3,4-オキサジアゾール-2-イル}アミノ)ピロリジン-2-オン
(3S,4R)-4-(2,6-ジフルオロ-4-メトキシフェニル)-3-({5-[4-(プロパン-2-イル)フェニル]-1,3,4-オキサジアゾール-2-イル}アミノ)ピロリジン-2-オン
(3S,4R)-3-({5-[4-(4-クロロフェノキシ)フェニル]-1,3,4-オキサジアゾール-2-イル}アミノ)-4-(2,6-ジフルオロ-4-メトキシフェニル)ピロリジン-2-オン
(3S,4R)-3-({5-[2-(4-クロロフェニル)シクロプロピル]-1,3,4-オキサジアゾール-2-イル}アミノ)-4-(2,6-ジフルオロ-4-メトキシフェニル)ピロリジン-2-オン
(3S,4R)-4-(2,6-ジフルオロ-4-メトキシフェニル)-3-({5-[2-(3,5-ジフルオロフェニル)シクロプロピル]-1,3,4-オキサジアゾール-2-イル}アミノ)ピロリジン-2-オン
(3S,4R)-3-({5-[2-(4-クロロフェニル)シクロプロピル]-1,3,4-オキサジアゾール-2-イル}アミノ)-4-(2,6-ジフルオロ-4-メトキシフェニル)ピロリジン-2-オン
(3S,4R)-4-(2,6-ジフルオロ-4-メトキシフェニル)-3-({5-[2-(2-メトキシフェニル)シクロプロピル]-1,3,4-オキサジアゾール-2-イル}アミノ)ピロリジン-2-オン
(3S,4R)-3-({5-[2-(3-クロロフェニル)シクロプロピル]-1,3,4-オキサジアゾール-2-イル}アミノ)-4-(2,6-ジフルオロ-4-メトキシフェニル)ピロリジン-2-オン
(3S,4R)-3-({5-[2-(4-クロロ-2-フルオロフェニル)シクロプロピル]-1,3,4-オキサジアゾール-2-イル}アミノ)-4-(2,6-ジフルオロ-4-メトキシフェニル)ピロリジン-2-オン
2-[4-(5-{[(3S,4R)-4-(2,6-ジフルオロ-4-メトキシフェニル)-2-オキソピロリジン-3-イル]アミノ}-1,3,4-オキサジアゾール-2-イル)フェノキシ]ピリジン-4-カルボニトリル
(3S,4R)-4-(2,6-ジフルオロ-4-メトキシフェニル)-3-({5-[4-(ピラジン-2-イルオキシ)フェニル]-1,3,4-オキサジアゾール-2-イル}アミノ)ピロリジン-2-オン
(3S,4R)-3-({6-クロロ-[1,2]オキサゾロ[4,5-b]ピリジン-3-イル}アミノ)-4-(2,6-ジフルオロ-4-メトキシフェニル)ピロリジン-2-オン
N-[2-(4-クロロフェニル)エチル]-5-{[(3S,4R)-4-(2,6-ジフルオロ-4-メトキシフェニル)-2-オキソピロリジン-3-イル]アミノ}-1,3,4-オキサジアゾール-2-カルボキサミド
6-[4-(5-{[(3S,4R)-4-(2,6-ジフルオロ-4-メトキシフェニル)-2-オキソピロリジン-3-イル]アミノ}-1,3,4-オキサジアゾール-2-イル)フェノキシ]ピリジン-3-カルボニトリル
4-[4-(5-{[(3S,4R)-4-(2,6-ジフルオロ-4-メトキシフェニル)-2-オキソピロリジン-3-イル]アミノ}-1,3,4-オキサジアゾール-2-イル)フェノキシ]ベンゾニトリル
(3S,4R)-4-(2,6-ジフルオロ-4-メトキシフェニル)-3-{[5-(4-{[6-(トリフルオロメチル)ピリジン-3-イル]オキシ}フェニル)-1,3,4-オキサジアゾール-2-イル]アミノ}ピロリジン-2-オン
6-[4-(5-{[(3S,4R)-4-(2,6-ジフルオロ-4-メトキシフェニル)-2-オキソピロリジン-3-イル]アミノ}-1,3,4-オキサジアゾール-2-イル)フェノキシ]ピリジン-2-カルボニトリル
(3S,4R)-3-[(5-{4-[(5-クロロピラジン-2-イル)オキシ]フェニル}-1,3,4-オキサジアゾール-2-イル)アミノ]-4-(2,6-ジフルオロ-4-メトキシフェニル)ピロリジン-2-オン
(3S,4R)-4-(2,6-ジフルオロ-4-メトキシフェニル)-3-[(5-{4-[(3-フルオロピリジン-2-イル)オキシ]フェニル}-1,3,4-オキサジアゾール-2-イル)アミノ]ピロリジン-2-オン
(3S,4R)-4-(2,6-ジフルオロ-4-メトキシフェニル)-3-[(5-{4-[(6-メトキシピリミジン-4-イル)オキシ]フェニル}-1,3,4-オキサジアゾール-2-イル)アミノ]ピロリジン-2-オン
(3S,4R)-4-(2,6-ジフルオロ-4-メトキシフェニル)-3-[(5-{4-[(6-メチルピラジン-2-イル)オキシ]フェニル}-1,3,4-オキサジアゾール-2-イル)アミノ]ピロリジン-2-オン
(3S,4R)-4-(2,6-ジフルオロ-4-メトキシフェニル)-3-[(5-{4-[(6-フルオロピリジン-2-イル)オキシ]フェニル}-1,3,4-オキサジアゾール-2-イル)アミノ]ピロリジン-2-オン
(3S,4R)-4-(2,6-ジフルオロ-4-メトキシフェニル)-3-[(5-{4-[(5-フルオロピリジン-2-イル)オキシ]フェニル}-1,3,4-オキサジアゾール-2-イル)アミノ]ピロリジン-2-オン
2-[4-(5-{[(3S,4R)-4-(2,6-ジフルオロ-4-メトキシフェニル)-2-オキソピロリジン-3-イル]アミノ}-1,3,4-オキサジアゾール-2-イル)フェノキシ]ピリジン-3-カルボニトリル
(3S,4R)-4-(2,6-ジフルオロ-4-メトキシフェニル)-3-[(5-{4-[(6-メトキシピリジン-2-イル)オキシ]フェニル}-1,3,4-オキサジアゾール-2-イル)アミノ]ピロリジン-2-オン
(3S,4R)-3-[(5-{4-[(4-クロロピリジン-2-イル)オキシ]フェニル}-1,3,4-オキサジアゾール-2-イル)アミノ]-4-(2,6-ジフルオロ-4-メトキシフェニル)ピロリジン-2-オン
からなる群より選択される化合物、またはそれらの医薬的に許容される塩。 (3S,4R)-3-{[5-(4-chlorophenyl)-1,3,4-thiadiazol-2-yl]amino}-4-(2,6-difluoro-4-methoxyphenyl)pyrrolidine-2 -on
(3S,4R)-4-(2,6-difluoro-4-methoxyphenyl)-3-[(5-phenyl-1,3,4-oxadiazol-2-yl)amino]pyrrolidin-2-one
(3S,4R)-4-(2,6-difluoro-4-methoxyphenyl)-3-{[5-(3,4-difluorophenyl)-1,3,4-oxadiazol-2-yl] Amino}pyrrolidin-2-one
(3S,4R)-4-(2,6-difluoro-4-methoxyphenyl)-3-{[5-(pyridin-3-yl)-1,3,4-oxadiazol-2-yl]amino }pyrrolidin-2-one
(3S,4R)-4-(2,6-difluoro-4-methoxyphenyl)-3-({5-[4-(trifluoromethoxy)phenyl]-1,3,4-oxadiazole-2- yl}amino)pyrrolidin-2-one
(3S,4R)-4-(2,6-difluoro-4-methoxyphenyl)-3-({5-[4-(trifluoromethyl)phenyl]-1,3,4-oxadiazole-2- yl}amino)pyrrolidin-2-one
4-(5-{[(3S,4R)-4-(2,6-difluoro-4-methoxyphenyl)-2-oxopyrrolidin-3-yl]amino}-1,3,4-oxadiazole- 2-yl)benzonitrile
(3S,4R)-4-(2,6-difluoro-4-methoxyphenyl)-3-({5-[6-(trifluoromethyl)pyridin-3-yl]-1,3,4-oxadi azol-2-yl}amino)pyrrolidin-2-one
(3S,4R)-4-(2,6-difluoro-4-methoxyphenyl)-3-{[5-(4-methylphenyl)-1,3,4-oxadiazol-2-yl]amino} Pyrrolidin-2-one
(3S,4R)-4-(2,6-difluoro-4-methoxyphenyl)-3-{[5-(4-fluorophenyl)-1,3,4-oxadiazol-2-yl]amino} Pyrrolidin-2-one
(3S,4R)-4-(2,6-difluoro-4-methoxyphenyl)-3-({5-[4-(1H-pyrazol-1-yl)phenyl]-1,3,4-oxazi azol-2-yl}amino)pyrrolidin-2-one
(3S,4R)-4-(2,6-difluoro-4-methoxyphenyl)-3-({5-[5-(trifluoromethyl)pyridin-2-yl]-1,3,4-oxadi azol-2-yl}amino)pyrrolidin-2-one
(3S,4R)-3-{[5-(4-chloro-2-fluorophenyl)-1,3,4-oxadiazol-2-yl]amino}-4-(2,6-difluoro-4 -Methoxyphenyl)pyrrolidin-2-one
(3S,4R)-3-{[5-(6-chloropyridin-3-yl)-1,3,4-oxadiazol-2-yl]amino}-4-(2,6-difluoro-4 -Methoxyphenyl)pyrrolidin-2-one
(3S,4R)-4-(2,6-difluoro-4-methoxyphenyl)-3-({5-[4-(difluoromethyl)phenyl]-1,3,4-oxadiazol-2-yl }amino)pyrrolidin-2-one
(3S,4R)-4-(2,6-difluoro-4-methoxyphenyl)-3-[(5-{4-[(trifluoromethyl)sulfanyl]phenyl}-1,3,4-oxadiazole -2-yl)amino]pyrrolidin-2-one
(3S,4R)-4-(2,6-difluoro-4-methoxyphenyl)-3-[(5-{4-[(1,1,2,2,2-pentafluoroethyl)sulfanyl]phenyl} -1,3,4-oxadiazol-2-yl)amino]pyrrolidin-2-one
(3S,4R)-3-{[5-(4-chlorophenyl)-1,3,4-oxadiazol-2-yl]amino}-4-(2,6-difluoro-4-methoxyphenyl)- 1-Methylpyrrolidin-2-one
(3S,4R)-4-(2,6-difluoro-4-methoxyphenyl)-3-({5-[4-(difluoromethyl)phenyl]-1,2-oxazol-3-yl}amino)pyrrolidine -2 - on
(3S,4R)-4-(2,6-difluoro-4-methoxyphenyl)-3-({5-[4-(trifluoromethoxy)phenyl]-1,2-oxazol-3-yl}amino) Pyrrolidin-2-one
(3S,4R)-4-(2,6-difluoro-4-methoxyphenyl)-3-{[5-(4-trifluoromethanesulfinylphenyl)-1,3,4-oxadiazol-2-yl] Amino}pyrrolidin-2-one
(3S,4R)-4-(2,6-difluoro-4-methoxyphenyl)-3-[(5-{4-[(difluoromethyl)sulfanyl]phenyl}-1,3,4-oxadiazole- 2-yl)amino]pyrrolidin-2-one
(3S,4R)-4-(2,6-difluoro-4-methoxyphenyl)-3-[(5-{6-[(trifluoromethyl)sulfanyl]pyridin-3-yl}-1,3,4 -Oxadiazol-2-yl)amino]pyrrolidin-2-one
(3S,4R)-3-{[5-(6-chloropyridin-3-yl)-1,3,4-thiadiazol-2-yl]amino}-4-(2,6-difluoro-4-methoxy Phenyl)pyrrolidin-2-one
(3S,4R)-4-(2,6-difluoro-4-methoxyphenyl)-3-{[5-(4-fluorophenyl)-1,3,4-thiadiazol-2-yl]amino}pyrrolidine- 2-on
(3S,4R)-4-(2,6-difluoro-4-methoxyphenyl)-3-({5-[6-(trifluoromethyl)pyridin-3-yl]-1,3,4-thiadiazole- 2-yl}amino)pyrrolidin-2-one
(3S,4R)-4-(2,6-difluoro-4-methoxyphenyl)-3-({5-[4-(propan-2-yloxy)phenyl]-1,3,4-oxadiazole- 2-yl}amino)pyrrolidin-2-one
(3S,4R)-4-(2,6-difluoro-4-methoxyphenyl)-3-({5-[4-(difluoromethoxy)phenyl]-1,3,4-oxadiazol-2-yl }amino)pyrrolidin-2-one
(3S,4R)-4-(2,6-difluoro-4-methoxyphenyl)-3-({5-[4-(propan-2-yl)phenyl]-1,3,4-oxadiazole- 2-yl}amino)pyrrolidin-2-one
(3S,4R)-3-({5-[4-(4-chlorophenoxy)phenyl]-1,3,4-oxadiazol-2-yl}amino)-4-(2,6-difluoro- 4-Methoxyphenyl)pyrrolidin-2-one
(3S,4R)-3-({5-[2-(4-chlorophenyl)cyclopropyl]-1,3,4-oxadiazol-2-yl}amino)-4-(2,6-difluoro- 4-Methoxyphenyl)pyrrolidin-2-one
(3S,4R)-4-(2,6-difluoro-4-methoxyphenyl)-3-({5-[2-(3,5-difluorophenyl)cyclopropyl]-1,3,4-oxadi azol-2-yl}amino)pyrrolidin-2-one
(3S,4R)-3-({5-[2-(4-chlorophenyl)cyclopropyl]-1,3,4-oxadiazol-2-yl}amino)-4-(2,6-difluoro- 4-Methoxyphenyl)pyrrolidin-2-one
(3S,4R)-4-(2,6-difluoro-4-methoxyphenyl)-3-({5-[2-(2-methoxyphenyl)cyclopropyl]-1,3,4-oxadiazole- 2-yl}amino)pyrrolidin-2-one
(3S,4R)-3-({5-[2-(3-chlorophenyl)cyclopropyl]-1,3,4-oxadiazol-2-yl}amino)-4-(2,6-difluoro- 4-Methoxyphenyl)pyrrolidin-2-one
(3S,4R)-3-({5-[2-(4-chloro-2-fluorophenyl)cyclopropyl]-1,3,4-oxadiazol-2-yl}amino)-4-(2 ,6-difluoro-4-methoxyphenyl)pyrrolidin-2-one
2-[4-(5-{[(3S,4R)-4-(2,6-difluoro-4-methoxyphenyl)-2-oxopyrrolidin-3-yl]amino}-1,3,4-oxa Diazol-2-yl)phenoxy]pyridine-4-carbonitrile
(3S,4R)-4-(2,6-difluoro-4-methoxyphenyl)-3-({5-[4-(pyrazin-2-yloxy)phenyl]-1,3,4-oxadiazole- 2-yl}amino)pyrrolidin-2-one
(3S,4R)-3-({6-chloro-[1,2]oxazolo[4,5-b]pyridin-3-yl}amino)-4-(2,6-difluoro-4-methoxyphenyl) Pyrrolidin-2-one
N-[2-(4-chlorophenyl)ethyl]-5-{[(3S,4R)-4-(2,6-difluoro-4-methoxyphenyl)-2-oxopyrrolidin-3-yl]amino}- 1,3,4-oxadiazole-2-carboxamide
6-[4-(5-{[(3S,4R)-4-(2,6-difluoro-4-methoxyphenyl)-2-oxopyrrolidin-3-yl]amino}-1,3,4-oxa Diazol-2-yl)phenoxy]pyridine-3-carbonitrile
4-[4-(5-{[(3S,4R)-4-(2,6-difluoro-4-methoxyphenyl)-2-oxopyrrolidin-3-yl]amino}-1,3,4-oxa Diazol-2-yl)phenoxy]benzonitrile
(3S,4R)-4-(2,6-difluoro-4-methoxyphenyl)-3-{[5-(4-{[6-(trifluoromethyl)pyridin-3-yl]oxy}phenyl)- 1,3,4-Oxadiazol-2-yl]amino}pyrrolidin-2-one
6-[4-(5-{[(3S,4R)-4-(2,6-difluoro-4-methoxyphenyl)-2-oxopyrrolidin-3-yl]amino}-1,3,4-oxa Diazol-2-yl)phenoxy]pyridine-2-carbonitrile
(3S,4R)-3-[(5-{4-[(5-chloropyrazin-2-yl)oxy]phenyl}-1,3,4-oxadiazol-2-yl)amino]-4- (2,6-difluoro-4-methoxyphenyl)pyrrolidin-2-one
(3S,4R)-4-(2,6-difluoro-4-methoxyphenyl)-3-[(5-{4-[(3-fluoropyridin-2-yl)oxy]phenyl}-1,3, 4-Oxadiazol-2-yl)amino]pyrrolidin-2-one
(3S,4R)-4-(2,6-difluoro-4-methoxyphenyl)-3-[(5-{4-[(6-methoxypyrimidin-4-yl)oxy]phenyl}-1,3, 4-Oxadiazol-2-yl)amino]pyrrolidin-2-one
(3S,4R)-4-(2,6-difluoro-4-methoxyphenyl)-3-[(5-{4-[(6-methylpyrazin-2-yl)oxy]phenyl}-1,3, 4-Oxadiazol-2-yl)amino]pyrrolidin-2-one
(3S,4R)-4-(2,6-difluoro-4-methoxyphenyl)-3-[(5-{4-[(6-fluoropyridin-2-yl)oxy]phenyl}-1,3, 4-Oxadiazol-2-yl)amino]pyrrolidin-2-one
(3S,4R)-4-(2,6-difluoro-4-methoxyphenyl)-3-[(5-{4-[(5-fluoropyridin-2-yl)oxy]phenyl}-1,3, 4-Oxadiazol-2-yl)amino]pyrrolidin-2-one
2-[4-(5-{[(3S,4R)-4-(2,6-difluoro-4-methoxyphenyl)-2-oxopyrrolidin-3-yl]amino}-1,3,4-oxa Diazol-2-yl)phenoxy]pyridine-3-carbonitrile
(3S,4R)-4-(2,6-difluoro-4-methoxyphenyl)-3-[(5-{4-[(6-methoxypyridin-2-yl)oxy]phenyl}-1,3, 4-Oxadiazol-2-yl)amino]pyrrolidin-2-one
(3S,4R)-3-[(5-{4-[(4-chloropyridin-2-yl)oxy]phenyl}-1,3,4-oxadiazol-2-yl)amino]-4- A compound selected from the group consisting of (2,6-difluoro-4-methoxyphenyl)pyrrolidin-2-one, or a pharmaceutically acceptable salt thereof.
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201862771196P | 2018-11-26 | 2018-11-26 | |
US62/771,196 | 2018-11-26 | ||
US201962819832P | 2019-03-18 | 2019-03-18 | |
US62/819,832 | 2019-03-18 | ||
PCT/US2019/062905 WO2020112583A1 (en) | 2018-11-26 | 2019-11-25 | Pyrrolidinone derivatives as formyl peptide 2 receptor agonists |
Publications (3)
Publication Number | Publication Date |
---|---|
JP2022508218A JP2022508218A (en) | 2022-01-19 |
JPWO2020112583A5 true JPWO2020112583A5 (en) | 2022-12-02 |
JP7398455B2 JP7398455B2 (en) | 2023-12-14 |
Family
ID=68848531
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2021529452A Active JP7398455B2 (en) | 2018-11-26 | 2019-11-25 | Pyrazolone formyl peptide 2 receptor agonist |
Country Status (7)
Country | Link |
---|---|
US (1) | US20220002281A1 (en) |
EP (1) | EP3887366B1 (en) |
JP (1) | JP7398455B2 (en) |
KR (1) | KR20210095897A (en) |
CN (1) | CN113166134A (en) |
ES (1) | ES2964299T3 (en) |
WO (1) | WO2020112583A1 (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2022011084A1 (en) * | 2020-07-09 | 2022-01-13 | Bristol-Myers Squibb Company | Oxopyrrolidine fpr2 agonists |
KR20230051525A (en) * | 2020-08-12 | 2023-04-18 | 브리스톨-마이어스 스큅 컴퍼니 | Oxopyrrolidine Urea FPR2 Agonist |
JP2023546371A (en) * | 2020-10-09 | 2023-11-02 | ブリストル-マイヤーズ スクイブ カンパニー | Aminoimidazole FPR2 agonist |
EP4281452A1 (en) * | 2021-01-21 | 2023-11-29 | Beijing Tiantan Hospital | Modulators of fpr1 and methods of using the same |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TN2016000210A1 (en) * | 2013-11-28 | 2017-10-06 | Kyorin Seiyaku Kk | Urea derivative or pharmacologically acceptable salt thereof. |
TW201815762A (en) * | 2016-09-21 | 2018-05-01 | 德商歌林達有限公司 | 6-membered cyclic amines or lactames substituted with urea and phenyl |
JP2020015664A (en) * | 2016-11-21 | 2020-01-30 | 宇部興産株式会社 | Nitrogen-containing polycyclic heterocyclic derivative |
-
2019
- 2019-11-25 ES ES19818484T patent/ES2964299T3/en active Active
- 2019-11-25 WO PCT/US2019/062905 patent/WO2020112583A1/en unknown
- 2019-11-25 KR KR1020217019403A patent/KR20210095897A/en unknown
- 2019-11-25 US US17/295,092 patent/US20220002281A1/en active Pending
- 2019-11-25 JP JP2021529452A patent/JP7398455B2/en active Active
- 2019-11-25 CN CN201980077329.9A patent/CN113166134A/en active Pending
- 2019-11-25 EP EP19818484.8A patent/EP3887366B1/en active Active
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU2396269C2 (en) | Heteroaryl-substituted piperidine derivatives as hepatic carnitine palmitoyltransferase (l-cpt1) inhibitors | |
JP2018535999A5 (en) | ||
IL258577A (en) | 2,4-dihydroxy-nicotinamides as apj agonists | |
RU2352568C2 (en) | [1,2,4]oxadiazoles (versions), methods of obtaining them, pharmaceutical composition and metod of inhibiting activation of metabotropic glutamate receptors - 5 | |
JP2006503009A5 (en) | ||
JP2015528022A5 (en) | ||
JP5036316B2 (en) | Aryloxy-substituted benzimidazole derivatives | |
IL303196A (en) | Heteroaryl substituted pyridines and methods of use | |
JP2015517580A5 (en) | ||
JP2018530591A5 (en) | ||
JP2007530690A5 (en) | ||
RU2009147733A (en) | Pyridylpiperidine Orexin Receptor Antagonists | |
JP2010533158A5 (en) | ||
JP2013523819A5 (en) | ||
JP2006502134A5 (en) | ||
RU2014152625A (en) | Azadecaline Condensed with Heteroaryl Ketones - Modulators of Glucocorticoid Receptors | |
JP2010502615A5 (en) | ||
JP2013501729A5 (en) | ||
RU2012133475A (en) | KINURENIN-3-MONOOXYGENASE INHIBITORS, PHARMACEUTICAL COMPOSITIONS AND WAYS OF THEIR APPLICATION | |
JP2007523208A5 (en) | ||
IL263511A (en) | 1h-pyrazolo[4,3-b]pyridines as pde1 inhibitors | |
JP2007528887A5 (en) | ||
RU2003112610A (en) | Pyrazole derivatives for the treatment of virx diseases | |
JP2017501981A5 (en) | ||
JP2004511469A5 (en) |